According to Greek mythology, Scylla and Charybdis were two fearsome monsters who threatened Odysseus's fleet of ships as they passed through the Strait of Messina. The names of these legendary creatures have now re-emerged as the identifiers of two cell growth regulatory genes in the fruit fly, Drosophila melanogaster. Two recent reports in Genes and Development identify scylla and charybdis and their mammalian orthologs, REDD1 and REDD2, as key players in the stress-response network that coordinates cell growth with the availability of sufficient oxygen to support anabolic metabolism [1,2]. Genetic studies in Drosophila revealed that scylla acted downstream of AKT and upstream of TSC1/2, and, by inference, placed scylla upstream of Rheb/TOR as well. These genetic data were confirmed in biochemical experiments that demonstrated a ∼ ∼50% reduction in S6K activity in fly tissues from scylla mutants. In Drosophila, the PI 3-kinase-AKT-TOR signaling axis promotes cell growth under 
formation of benign tumors, called hamartomas, in organs such as the heart and brain. Interestingly, hamartomatous lesions are also common in several other hereditary diseases in humans, including Cowden's disease and Peutz-Jeghers Syndrome which are caused by functional inactivation of the lipid phosphatase PTEN and of the serine/threonine kinase LKB1, respectively. The phenotypic overlap among these three genetic diseases is more than coincidental, because PTEN, LKB1 and TSC all serve as upstream regulators of TOR signaling [5] [6] [7] .
The mechanism through which TSC integrates into the TOR signaling pathway and downregulates cell growth has recently been elucidated. TSC is a heterodimeric complex comprising TSC1 and TSC2, and the TSC2 subunit is a GTPaseactivating protein (GAP) for the Ras-related GTPase Rheb [5, 8] 
